{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:41:48Z","timestamp":1792395708847,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Pre-eclampsia is a pregnancy disorder associated with substantial maternal and perinatal morbidity and mortality worldwide. Low-dose aspirin initiated during the first trimester can reduce the risk of preterm pre-eclampsia, leading some to advocate universal prophylaxis during pregnancy. Although simple in principle, this approach would unnecessarily expose many low-risk women to treatment while providing limited absolute benefit. Moreover, the effectiveness of aspirin depends on treatment adherence, which may be reduced without individualized risk assessment. Current evidence supports targeted aspirin prophylaxis following first-trimester risk stratification rather than universal treatment, an approach that has not been evaluated in adequately powered randomized trials.<\/jats:p>","DOI":"10.1097\/grf.0000000000001054","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:00:10Z","timestamp":1787637610000},"page":"434-440","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Against"],"prefix":"10.1097","volume":"69","author":[{"given":"Madeleine P.","family":"Kendall","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio","family":"da Silva Costa","sequence":"additional","affiliation":[{"name":"Maternal Fetal Medicine Unit, Gold Coast University Hospital"},{"name":"School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinka","family":"Oyelese","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Beth Israel Deaconess Medical Center"},{"name":"Fetal Surgery and Care Center (FSCC), Department of Surgery, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-3592","authenticated-orcid":false,"given":"Daniel L.","family":"Rolnik","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"R1-20261019","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N Engl J Med"},{"key":"R2-20261019","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","article-title":"Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"R3-20261019","doi-asserted-by":"crossref","first-page":"e003497","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R4-20261019","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(16)31575-6","article-title":"Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"R5-20261019","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R6-20261019","first-page":"551","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"R7-20261019","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20261019","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20261019","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1471-0528.17370","article-title":"Preterm and term pre-eclampsia: Relative burdens of maternal and perinatal complications","volume":"130","author":"von Dadelszen","year":"2023","journal-title":"BJOG"},{"key":"R11-20261019","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R12-20261019","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl 1","key":"R13-20261019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145 Suppl 1","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R14-20261019","doi-asserted-by":"crossref","first-page":"141 e1","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant women?","volume":"216","author":"Mone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20261019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R16-20261019","doi-asserted-by":"crossref","first-page":"62 e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20261019","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ijgo.14049","article-title":"Routine first trimester combined screening for preterm preeclampsia in Australia: a multicenter clinical implementation cohort study","volume":"158","author":"Rolnik","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"R18-20261019","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1471-0528.16361","article-title":"Implementation of routine first trimester combined screening for pre-eclampsia: a clinical effectiveness study","volume":"128","author":"Guy","year":"2021","journal-title":"BJOG"},{"key":"R19-20261019","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/uog.26233","article-title":"Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain","volume":"62","author":"Cuenca-Gomez","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R20-20261019","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.preghy.2021.10.005","article-title":"External validation of first trimester combined screening for pre-eclampsia in Brazil: an observational study","volume":"26","author":"Rezende","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"R21-20261019","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/uog.26183","article-title":"Pre-eclampsia screening in Denmark (PRESIDE): national validation study","volume":"61","author":"Riishede","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R22-20261019","doi-asserted-by":"crossref","first-page":"101803","DOI":"10.1016\/j.ajogmf.2025.101803","article-title":"Performance of a first-trimester combined screening for preterm preeclampsia in the United States population using the fetal medicine foundation competing risks model","volume":"7","author":"Martins","year":"2025","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R23-20261019","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/CIRCULATIONAHA.124.069907","article-title":"Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia","volume":"150","author":"Nguyen-Hoang","year":"2024","journal-title":"Circulation"},{"key":"R24-20261019","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20105","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R25-20261019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/uog.13275","article-title":"First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women","volume":"43","author":"Velauthar","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R26-20261019","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R27-20261019","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1471-0528.17598","article-title":"First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study","volume":"131","author":"Nzelu","year":"2024","journal-title":"BJOG"},{"key":"R28-20261019","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R29-20261019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11096-013-9864-y","article-title":"Adherence to medication for chronic disorders during pregnancy: results from a multinational study","volume":"36","author":"Lupattelli","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"R30-20261019","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ajog.2026.02.014","article-title":"Combined impact of first-trimester risk and aspirin adherence on preterm preeclampsia prevention","volume":"234","author":"Rolnik","year":"2026","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20261019","doi-asserted-by":"crossref","first-page":"685 e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R32-20261019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12872-024-03827-w","article-title":"Levels of adherence to treatment, illness perception and acceptance of illness in patients with coronary artery disease - descriptive and correlational study","volume":"24","author":"Dugunchi","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R33-20261019","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12875-022-01918-1","article-title":"Perception of risk of hypertension related complications and adherence to antihypertensive drugs: a primary healthcare based cross-sectional study","volume":"23","author":"Shiraly","year":"2022","journal-title":"BMC Prim Care"},{"key":"R34-20261019","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R35-20261019","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"R36-20261019","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R37-20261019","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"R38-20261019","doi-asserted-by":"crossref","first-page":"95 e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R39-20261019","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00535-015-1038-3","article-title":"Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective","volume":"50","author":"Lanas","year":"2015","journal-title":"J Gastroenterol"},{"key":"R40-20261019","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R41-20261019","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/AOG.0000000000005514","article-title":"Neurodevelopment of children whose mothers were randomized to low-dose aspirin during pregnancy","volume":"143","author":"Hoffman","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R42-20261019","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down\u2019s syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N Engl J Med"},{"key":"R43-20261019","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"R44-20261019","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"R45-20261019","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.2022.3337","article-title":"Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force","volume":"327","author":"Guirguis-Blake","year":"2022","journal-title":"JAMA"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GRF.0000000000001054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:00:34Z","timestamp":1792393234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/GRF.0000000000001054"}},"subtitle":["Treating All Pregnant Women With Aspirin to Prevent Pre-eclampsia"],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000001054","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"2026-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}